CAS: 388630-75-9 - 1,3,4-Thiadiazole-2-methanamine, 5-methyl-, hydrochloride (1:1)
Fórmula:C4H7N3S·ClH
InChI:InChI=1S/C4H7N3S.ClH/c1-3-6-7-4(2-5)8-3;/h2,5H2,1H3;1H
Chave InChI:InChIKey=LJFOGPILZPMPEV-UHFFFAOYSA-N
SMILES:Cl.N=1N=C(SC1C)CN
- Sinónimos:
- [(5-Methyl-1,3,4-thiadiazol-2-yl)methyl]amine hydrochloride
- 1,3,4-Thiadiazole-2-methanamine, 5-methyl-, hydrochloride (1:1)
- 1,3,4-Thiadiazole-2-methanamine, 5-methyl-, monohydrochloride
- (5-Methyl-1,3,4-thiadiazol-2-yl)methanamine hydrochloride
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | (5-METHYL-1,3,4-THIADIAZOL-2-YL)METHANAMINE HCL REF: IN-DA00I7P7CAS: 388630-75-9 | 98% | A consultar | Qui 12 Dez 24 |
 | (5-Methyl-1,3,4-thiadiazol-2-yl)methanamine hydrochloride REF: 10-F724692CAS: 388630-75-9 | 95+% | A consultar | Sex 27 Dez 24 |
 | 5-Methyl-1,3,4-thiadiazole-2-methanamine HCl REF: 3D-FM165554CAS: 388630-75-9 | Min. 95% | A consultar | Qui 23 Jan 25 |
(5-METHYL-1,3,4-THIADIAZOL-2-YL)METHANAMINE HCL
CAS:388630-75-9
Fórmula:
C4H8ClN3S
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
165.6444
Ref: IN-DA00I7P7
| 1g | A consultar | ||
| 100mg | 178,00 € | ||
| 250mg | 301,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 12 de Dezembro de 2024
(5-Methyl-1,3,4-thiadiazol-2-yl)methanamine hydrochloride
CAS:388630-75-9
Pureza:
95+%
Peso molecular:
165.63999938964844
Ref: 10-F724692
| 1g | 691,00 € | ||
| 5g | A consultar | ||
| 100mg | 185,00 € | ||
| 250mg | 294,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 27 de Dezembro de 2024
5-Methyl-1,3,4-thiadiazole-2-methanamine HCl
CAS:388630-75-9
Please enquire for more information about 5-Methyl-1,3,4-thiadiazole-2-methanamine HCl including the price, delivery time and more …
Fórmula:
C4H8ClN3S
Pureza:
Min. 95%
Peso molecular:
165.65 g/mol
Ref: 3D-FM165554
| 1g | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 23 de Janeiro de 2025
